News AlzChem Group AG

Equities

ACT

DE000A2YNT30

Market Closed - Xetra Other stock markets 11:36:12 2024-05-27 am EDT			5-day change	1st Jan Change
44.8 ^EUR	+1.36%		+1.82%	+72.31%

Apr. 30	Transcript : AlzChem Group AG, Q1 2024 Earnings Call, Apr 30, 2024
Apr. 30	AlzChem Group AG Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AlzChem : Eminex® - Research project and biogas	May. 16	PU
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved	May. 07	EQ
Alzchem : receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved	May. 07	PU
Transcript : AlzChem Group AG, Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024	Apr. 30	EQ
AlzChem : Quarterly Statement Q1 2024	Apr. 30	PU
AlzChem : Corporate News Q1 2024	Apr. 30	PU
Alzchem : seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024	Apr. 30	PU
AlzChem Group AG Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Young researchers in action: Chemistry Olympiad as a guest at Alzchem	Apr. 25	PU
AlzChem : Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212	Mar. 21	PU
Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding	Mar. 15	EQ
German arms industry receives EU millions for projects	Mar. 15	DP
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments	Mar. 11	EQ
Transcript : AlzChem Group AG, 2023 Earnings Call, Mar 01, 2024	Mar. 01
Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success	Mar. 01	EQ
AlzChem Group AG Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
AlzChem Group AG Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
AFR: Alzchem Group AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Feb. 21	EQ
Alzchem Group AG: Long-Covid: New clinical studies show high efficacy of creatine supplementation	Jan. 11	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AlzChem Group AG

Equities

ACT

DE000A2YNT30

Summary

Filters